Seer (SEER) Operating Leases (2021 - 2026)
Seer (SEER) recorded quarterly Operating Leases of $20.4 million in Q1 2026, down 3.29% quarter-over-quarter from $21.1 million in Q4 2025, and down 11.48% on a YoY basis from $23.0 million in Q1 2025.
Seer (SEER) Operating Leases (2021 - 2026) Analysis & Trends
Seer's Operating Leases history runs 6 years deep, the most recent figure standing at $20.4 million for Q1 2026.
- In Q1 2026, Operating Leases fell 11.48% year-over-year to $20.4 million; the TTM figure through Mar 2026 stood at $20.4 million (down 11.48% YoY), while the FY2025 annual figure was $21.1 million, down 10.89% from the prior year.
- Operating Leases was $20.4 million for Q1 2026 at Seer, down from $21.1 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $30.2 million in Q1 2022 to a low of $20.4 million in Q1 2026.
- Historically, Operating Leases has averaged $25.7 million across 5 years, with a median of $25.4 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Operating Leases rose 24.81% in 2022, then fell 15.82% in 2024.
- A 5-year view of Operating Leases shows it stood at $28.0 million in 2022, then retreated by 7.38% to $26.0 million in 2023, then slipped by 8.9% to $23.7 million in 2024, then declined by 10.89% to $21.1 million in 2025, then dropped by 3.29% to $20.4 million in 2026.
- The last three Operating Leases figures came in at $20.4 million (Q1 2026), $21.1 million (Q4 2025), and $21.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.38 Mn |
| Dec 31, 2025 | 21.08 Mn |
| Sep 30, 2025 | 21.74 Mn |
| Jun 30, 2025 | 22.39 Mn |
| Mar 31, 2025 | 23.03 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 24.25 Mn |
| Jun 30, 2024 | 24.83 Mn |
| Mar 31, 2024 | 25.40 Mn |
| Dec 31, 2023 | 25.96 Mn |
| Sep 30, 2023 | 28.81 Mn |
| Jun 30, 2023 | 29.35 Mn |
| Mar 31, 2023 | 29.87 Mn |
| Dec 31, 2022 | 28.03 Mn |
| Sep 30, 2022 | 28.51 Mn |
| Jun 30, 2022 | 28.91 Mn |
| Mar 31, 2022 | 30.22 Mn |
| Dec 31, 2021 | 22.46 Mn |